Just in from Leo Kelt Hi, We will be issuing
Post# of 72440
Just in from Leo
Kelt
Hi,
Hi Leo.
In today's PR Dr.Menon said "We will be presenting the most recent data available from the clinical trials of Kevetrin hosted at Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center,"
Will these updates be available to shareholders over the course of the weekend as well?(I don't see where there is any media to listen in with).
Thank You,Jim